Vitaspring Biomedical Co. LtdOver The Counter Market:VSBC
- LAST PRICE15.0000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 15.0000
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Vitaspring Biomedical Co. Ltd | 3.1B | 3,311.3x | --- |
Xenon Pharmaceuticals Inc | 3.1B | -14.8x | --- |
Apogee Therapeutics Inc | 3.0B | -27.8x | --- |
SpringWorks Therapeutics Inc | 3.3B | -8.3x | --- |
IDEAYA Biosciences Inc | 3.0B | -19.2x | --- |
Iovance Biotherapeutics Inc | 3.3B | -6.2x | --- |
Company Information
Vitaspring Biomedical Co. Ltd. is focused on cell medical industry. The Company is engaged in the business of developing and marketing products that promote wellness and a healthy lifestyle. The Company invests in research and development of stem cell applications in regenerative medicine, establish advanced medical research centers and cell production centers and provides GTP standard stem cell preparations for the development of cellular drugs. The Company is focused on the fields of medicine, preventive health care, beauty, and anti-aging. It is also focused on developing X.MSC cytopharmaceuticals.
Contact Information
- Headquarters
- 400 Spectrum Center Dr. #1620 Baiyun DistrictIRVINE, CA, United States 92618
- Phone
- 949-202-9235
- Fax
- ---
Executives
- Chairperson of the Board, President, Director
- Pao-chi Chu
- Chief Executive Officer, Director
- Cheng-hsiang Kao
- Chief Technology Officer, Director
- Che-li Lin
- Technical Vice President, Director
- Yen-hsun Chen
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.1B |
|---|---|
Revenue (TTM) | $5.0M |
Shares Outstanding | 206.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $0.00 |
Book Value | $0.01 |
P/E Ratio | 3,311.3x |
Price/Sales (TTM) | 622.2 |
Price/Cash Flow (TTM) | 3,258.5x |
Operating Margin | 23.57% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
